DeepDx® Prostate
| Solution Type | AI Suite/Add-on |
|---|---|
| Deployment Environment | Clinical Diagnostics |
| Regulatory Clearance | Prostate Cancer – CE-IVD, Prostate Cancer – South Korea IVD |
| Target | Prostate Cancer |
| Platform Dependency | Requires Specific Platform |
| Deployment Options | Hybrid (Cloud analysis, local viewer) |
Be the first to review “DeepDx® Prostate” Cancel reply
Have you considered:
Compare Solutions
No products to compare
Get Pathology News Delivered to Your Inbox
News
Editor2026-08-14T06:49:00+00:00
OnePath Diagnostic Now Runs on elea’s AI-Native Pathology Operating System
Editor2026-08-14T06:49:00+00:00August 13, 2026|
Editor2026-08-12T08:47:23+00:00
A multisite survey on patient perspectives of breast cancer risk assessment and supplemental breast cancer screening tools
Editor2026-08-12T08:47:23+00:00August 12, 2026|
Editor2026-08-10T07:51:40+00:00
Keeping Digital Pathology Open: The Regulatory Framework Behind Concentriq AP-Dx
Editor2026-08-10T07:51:40+00:00August 12, 2026|
Editor2026-08-11T14:54:03+00:00
Lumea Climbs the 2026 Inc. 5000 Ranking, Reflecting Continued Rapid Growth
Editor2026-08-11T14:54:03+00:00August 11, 2026|
Editor2026-08-11T13:08:19+00:00
Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software
Editor2026-08-11T13:08:19+00:00August 11, 2026|
Editor2026-08-11T09:16:15+00:00
NPIC Summit 2026: Steering the Global Future of Digital Pathology
Editor2026-08-11T09:16:15+00:00August 11, 2026|
Editor2026-08-11T07:19:59+00:00
A guide for the deployment, validation, and accreditation of clinical digital pathology tools
Editor2026-08-11T07:19:59+00:00August 11, 2026|















Reviews
There are no reviews yet.